BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27347620)

  • 1. On finding the type and timing of salvage prostatectomy.
    Phillips J
    Can J Urol; 2016 Jun; 23(3):8278. PubMed ID: 27347620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer biochemical recurrence after salvage radiotherapy: first look into risk stratification and prognosis.
    Couture F; Tholomier C; Zorn KC
    BJU Int; 2018 Mar; 121(3):320-321. PubMed ID: 29480588
    [No Abstract]   [Full Text] [Related]  

  • 3. Salvage Treatment After Radical Prostatectomy.
    Parker C; Sydes MR
    Eur Urol; 2018 Feb; 73(2):166-167. PubMed ID: 28779975
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy.
    Chin JL
    Eur Urol; 2018 May; 73(5):808. PubMed ID: 29275832
    [No Abstract]   [Full Text] [Related]  

  • 5. Salvage lymphadenectomy in postprostatectomy patients with prostate-specific antigen recurrence.
    Suardi N; Briganti A; Salonia A; Rigatti P
    Curr Opin Urol; 2011 May; 21(3):237-40. PubMed ID: 21427585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for salvage lymphadenectomy as second line therapy post robotic radical prostatectomy?
    Goonewardene S; Cahill D
    J Robot Surg; 2016 Jun; 10(2):179-81. PubMed ID: 27083924
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathological characteristics of prostate cancer recurrence after radiation therapy: implications for focal salvage therapy.
    Leibovici D; Chiong E; Pisters LL; Guo CC; Ward JF; Andino L; Prokhorova IN; Troncoso P
    J Urol; 2012 Jul; 188(1):98-102. PubMed ID: 22578724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term results of adjuvant versus early salvage radiation therapy in pT3N0 prostate cancer after radical prostatectomy].
    Hermann RM; Christiansen H
    Strahlenther Onkol; 2018 Feb; 194(2):181-184. PubMed ID: 29264621
    [No Abstract]   [Full Text] [Related]  

  • 9. Third-generation cryosurgery for primary and recurrent prostate cancer.
    Han KR; Belldegrun AS
    BJU Int; 2004 Jan; 93(1):14-8. PubMed ID: 14678360
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy.
    Leventis AK; Shariat SF; Kattan MW; Butler EB; Wheeler TM; Slawin KM
    J Clin Oncol; 2001 Feb; 19(4):1030-9. PubMed ID: 11181666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.
    Servoll E; Sæter T; Vlatkovic L; Nesland JM; Waaler G; Axcrona K
    Scand J Urol; 2015 Jun; 49(3):218-23. PubMed ID: 25428750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.
    Leonardo C; Simone G; Papalia R; Franco G; Guaglianone S; Gallucci M
    Int J Urol; 2009 Jun; 16(6):584-6. PubMed ID: 19453762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of surgery in managing local recurrence following external-beam radiation therapy.
    Pontes JE
    Urol Clin North Am; 1994 Nov; 21(4):701-6. PubMed ID: 7526516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
    Taguchi S; Shiraishi K; Fukuhara H; Nakagawa K; Morikawa T; Naito A; Kakutani S; Takeshima Y; Miyazaki H; Nakagawa T; Fujimura T; Kume H; Homma Y
    Radiat Oncol; 2016 Jul; 11():102. PubMed ID: 27475986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery.
    Chang JH; Park W; Park JS; Pyo H; Huh SJ; Choi HY; Lee HM; Jeon SS; Seo SI
    Int J Urol; 2015 Jan; 22(1):82-7. PubMed ID: 25208624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low rate of circulating tumour cells (CTCs) in patients with PSA recurrence after radical prostatectomy referred to salvage radiotherapy.
    Gunnlaugsson A; Nilsson P; Kjellén E; Blom R
    Acta Oncol; 2016; 55(1):113-5. PubMed ID: 25920362
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapy.
    Stephenson AJ; Slawin KM; Bianco FJ; Scardino PT
    BJU Int; 2004 Dec; 94(9):1210-2. PubMed ID: 15610088
    [No Abstract]   [Full Text] [Related]  

  • 18. Salvage radiotherapy for patients with rising PSA.
    Fossati N; Cozzarini C; Fiorino C; Gandaglia G; Montorsi F; Briganti A
    Lancet Oncol; 2016 Aug; 17(8):e314-e315. PubMed ID: 27511150
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
    Ward JF
    Eur Urol; 2010 Mar; 57(3):444-5. PubMed ID: 19303198
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment on: Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
    Patel A
    Eur Urol; 2010 Mar; 57(3):444. PubMed ID: 19303196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.